The MS team reviews the pharmacologic options available for patients with MS who experience extreme fatigue by way of the ponesimod phase III OPTIMUM trial and phase III TRIUMPHANT-MS trial.
Access resources and learn more about the invisible symptoms of MS at [ Ссылка ].
- - - - -
In “The Impact of Invisible Symptoms of MS,” an expert panel of clinicians from the Stony Brook Neurosciences Institute meet with Lillian, a woman living with MS for 30 years, to learn more about the unseen symptoms that impact life with multiple sclerosis.
Featuring: Patricia Coyle, MD
Director, MS Comprehensive Care Center
Patricia Melville, RN, NP-C, CCRC, MSCN
Supporting Specialist
Thomas Preston, PhD, ABPP/CN
Director, Neuropsychology Services
Presented by Psychiatrist.com and CMSC.
